UCLA

Natural killer cells
#CAR-T #Natural killer cells #Oncology #Ovarian cancer #UCLA

Scientists develop CAR-NKT cell therapy for ovarian cancer

A new type of immunotherapy called CAR-NKT cell therapy has been shown to be more effective at fighting ovarian cancer than conventional CAR-T cell therapy.   Unlike current cellular immunotherapies that require patient-specific manufacturing and can cost hundreds of thousands of dollars, CAR-NKT cells can be produced… Read More

#Cancer Research #Editor's Choice #News

Pancreatic cancer
#Cancer vaccine #Colorectal cancer #Gene mutation #Oncology #Pancreatic cancer #UCLA

Off-the-shelf cancer vaccine shows promise in KRAS-driven cancers

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results in patients with pancreatic and colorectal cancer.  The study was led in part by investigators at the UCLA Health Jonsson Comprehensive Cancer Center and… Read More

#Cancer Research #Editor's Choice #News

#Brain cancer #Genetic profiling #Machine learning #Oncology #Precision medicine #UCLA

ML study identifies new glioblastoma treatment strategy

A new precision medicine approach that combines genetic and functional profiling could predict how glioblastoma will respond to therapy.  A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma becomes resistant to treatment and introduces a new approach that paves… Read More

#Cancer Research #Editor's Choice #News

Prostate cancer cells
#Bladder cancer #Immunotherapy #Oncology #Prostate cancer #UCLA

Immunotherapy with chemotherapy effective for rare cancers

New research has found that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate. A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, an immunotherapy drug, with… Read More

#Cancer Research #Editor's Choice #News